EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

Technologies · Scientific Intelligence

Computational research

Desk studies of three botanical actives, curcumin, quercetin and berberine, carried from molecular structure through solubility, extraction, formulation and stability to human exposure. Each of the 60 figures states what kind of evidence it is and ships with its data and the script that produced it.

Published dataThese studies analyze published measurements and run calculations with open-source tools. EUTECNIQ has not yet measured these compounds; where a figure uses simulated data or assumed inputs, it says so.

This program at a glance

60
figures, each with data, code and a status label
3
compounds followed from structure to exposure
17
figures that demonstrate a method on assumed inputs or plan an experiment
0
EUTECNIQ laboratory measurements so far

Part of the Large Botanical Model. This research supports the development of the platform; it is not evidence that a trained model exists. See the platform, its status and roadmap.

Status of the research

Six kinds of work, kept apart so none is mistaken for another.

The 60 figures are grouped by what they are. None of them shows that a trained Large Botanical Model exists.

Research grouped by evidence status
Kind of workWhat is in itCount
Completed computational researchFigures labeled Computed (20) and Benchmark simulation (1); the November 2026 surrogate benchmark on the platform page21 figures + 1 benchmark
Literature-based models and reanalysesMeasured (1, re-plotted), Literature-derived (6), Calibrated (10) and Predicted (5)22 figures
Illustrative numerical simulationsMethods shown on a simulator with assumed inputs15 figures
Proposed platform componentsKnowledge graph, data pipelines, specialized predictive models; see the maturity registerNone built
Planned laboratory validationFigures labeled Planned (2) and the six measurements below2 figures · 6 measurements
Commercially operational productsNone. EUTECNIQ Atlas and the supplement calculator are free public tools, separate from the platform.0
Three-dimensional set of five translucent ribbons, each a 90% credible band with a solid median line, showing plasma concentration over 24 hours for curcumin, two quercetin forms and two berberine fits.
  1. 1 Line: posterior median
  2. 2 Band: 90% credible interval

Data: FIG 032. Posterior median and 90% interval of the typical-subject curve for each published dataset (PyMC NUTS, 4 chains × 2,000 draws). Each curve is scaled to its own peak, so heights are not comparable across ribbons.

Three-dimensional rendering of a capsule dose and a rack of nine blood tubes labeled 0.5 to 24 hours. Each tube’s plasma layer rises to a peak at about 3 to 4 hours and falls by 24 hours. A monitor shows the fitted concentration curve with a shaded band.
  1. 1 Dose
  2. 2 Plasma height: posterior median concentration at each sampling time
  3. 3 Bayesian model: median and 90% band; dots are the tubes

Data: FIG 032, curcumin conjugates: posterior median plasma concentration of the typical subject at each time (PyMC, calibrated on Vareed et al., Cancer Epidemiol Biomarkers Prev 2008). Plasma height is scaled to the peak; the screen shows the median and 90% interval. Tubes and dose are schematic.

Part of the case for why EUTECNIQ is different.

Findings

What the calculations show so far

The most useful results are the ones that change what should be measured next.

  • A conformer search of 100 starts, the size of an earlier version of this calculation, stops 0.49 kcal/mol above the lowest diketo curcumin minimum; 1,500 starts reach it at start 539. Quercetin and berberine reproduce the earlier minima to four decimals. FIG 004
  • In explicit water, curcumin's intramolecular enol hydrogen bond stays intact (O···O under 2.8 Å) in 88% of frames across 2 replicates, so that hydroxyl is largely unavailable to the solvent. FIG 009
  • Seven published first pKa values for quercetin, from 5.81 to 8.45, put its neutral fraction at pH 6.8 anywhere between 0.09 and 0.98. Any pH-dependent model of quercetin inherits that spread. FIG 007
  • Two published aqueous solubilities of quercetin disagree by nearly four orders of magnitude, while organic-solvent data from different laboratories agree within a few percent. FIG 014
  • Of the human studies compiled for FIG 033, only one reports quantifiable parent curcumin; in it, unconjugated curcumin is about 0.3% of total curcumin exposure. Claims built on total curcumin describe conjugates. FIG 033
  • Reported half-lives of curcumin near pH 7 and body temperature run from about 9 minutes in phosphate buffer to several hours in protein-containing media. FIG 026
  • Animal formulation studies report 1.6- to 4.1-fold exposure gains for berberine and quercetin, but per mg/kg their reference arms report about 70 (rat) and 16,000 (rabbit) times the peak concentration of the human berberine study. FIG 029
  • A re-analysis of a published nine-run quercetin dispersion design finds neither factor significant at the 5% level, although the paper ranks them. FIG 024
  • Berberine's published summary data fit fast absorption with slow elimination and the reverse equally well; intravenous or metabolite data are needed to separate them. FIG 038

Reading the figures

Every figure carries one of eight evidence labels

The label describes the figure as a whole. A calibrated model plotted against the measurements it was fitted to is calibrated, not measured.

Schematic, How each computational study is built: Published data Inputs with their sources Script Each figure made by code Figure and data 60 figures, each with its data Evidence label One of eight labels Planned measurement Six experiments, not results Desk studies of curcumin, quercetin and berberine. The planned measurements are proposals; no laboratory is operating.
Schematic Drawn by EUTECNIQ from the text of this page. Icons are schematic and not to scale.
Evidence labels and figure counts
LabelMeaningFigures
MeasuredValues measured in a laboratory and reported by the cited source, re-plotted without modeling.1
Literature-derivedPublished values compiled or converted (for example, percentages to half-lives) with no fitted model.6
ComputedCalculated here from defined inputs with a stated method: force-field energies, regressions, statistics.20
CalibratedA model whose parameters were fitted to published human or laboratory data, with posterior uncertainty.10
PredictedA calibrated or trained model applied beyond the data it was fitted to; read as a hypothesis.5
IllustrativeA method demonstrated on a simulator or on simulated data with stated, assumed inputs. Not a result about any material.15
Benchmark simulationA numerical method checked against an accepted published reference solution.1
PlannedAn experiment or analysis designed but not yet carried out.2

Studies

Nine study areas, from force fields to quality systems

  1. Molecular structure7 figures
  2. Molecular dynamics3 figures
  3. Solubility and solvent selection5 figures
  4. Extraction and process7 figures
  5. Formulation and stability11 figures
  6. Pharmacokinetics10 figures
  7. Uncertainty and inference8 figures
  8. Optimization and design space5 figures
  9. Quality systems and validation4 figures

Methods, software versions, random seeds and verification checks are on the methods page.

Next measurements

Six laboratory measurements that would retire the largest uncertainties

These are planned experiments, not results. Each one is chosen because a calculation here cannot be settled without it.

Planned measurements
QuantityMeasurementWhat it settles
Quercetin aqueous solubilityShake-flask measurement at 25 and 37 °C with solid-form control (XRPD before and after), pH-stat, and HPLC-UV; three independent lots.Resolves the nearly 10,000-fold disagreement in FIG 014.
Quercetin first pKaPotentiometric and UV-metric titration in a co-solvent series extrapolated to water (Yasuda–Shedlovsky).Fixes the speciation spread in FIG 007.
Curcumin fusion enthalpyDifferential scanning calorimetry of the crystal form used for solubility work.Replaces the two estimated ideal-solubility bounds in FIG 013.
Tautomer and torsion energiesDensity-functional calculations with implicit solvent on the MMFF94s minima of FIG 002.Tests the force-field barriers in FIG 005 and compares the two curcumin tautomers on one energy scale.
Curcumin degradation in the product matrixFirst-order kinetics at three or more temperatures in the actual formulation, with product identification by LC-MS.Turns the broth-based surface of FIG 053 into a matrix-specific one.
Berberine formulation in peopleA crossover pharmacokinetic study against a reference product, measuring parent berberine and its main metabolites.The evidence gap marked in FIG 030.

Scientific Intelligence · The Ingredient Engine · Computational science and AI

Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.

Read the full notice

The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to start a development project?

Tell us about an ingredient you want to specify, verify or license. Questions? Email [email protected]